ArticleJournal of thrombosis and thrombolysis2017

Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases.

Milan R Vosko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.